SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028070
Filing Date
2018-11-07
Accepted
2018-11-07 16:32:10
Documents
58
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2018 FORM 10-Q alny-10q_20180930.htm 10-Q 2586642
2 EX-10.1 alny-ex101_251.htm EX-10.1 104292
3 EX-10.2 alny-ex102_250.htm EX-10.2 81971
4 EX-31.1 alny-ex311_9.htm EX-31.1 18237
5 EX-31.2 alny-ex312_11.htm EX-31.2 18335
6 EX-32.1 alny-ex321_10.htm EX-32.1 7095
7 EX-32.2 alny-ex322_8.htm EX-32.2 7070
8 GRAPHIC gowu2sy3tvak000001.jpg GRAPHIC 36867
  Complete submission text file 0001564590-18-028070.txt   9001993

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alny-20180930.xml EX-101.INS 2078112
10 XBRL TAXONOMY EXTENSION SCHEMA alny-20180930.xsd EX-101.SCH 47653
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20180930_cal.xml EX-101.CAL 48182
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20180930_def.xml EX-101.DEF 186536
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20180930_lab.xml EX-101.LAB 345170
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20180930_pre.xml EX-101.PRE 293497
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 181166786
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1